Dragonfly
is a biopharmaceutical company that researches and develops immunotherapies for the treatment of cancer... Read moreDragonfly
is a biopharmaceutical company that researches and develops immunotherapies for the treatment of cancer... Read more
News
Nov 07, 2024
PR Newswire
Press Release: Dragonfly : Dragonfly Therapeutics to Present Preclinical Data on Clinical-Stage DF6215, its Engineered IL-2R alpha-active Agonist, and DF9001, its EGFR-targeting TriNKET, at the Society for Immunotherapy of Cancer (SITC) Annual Conference
Aug 09, 2024
Endpoints News
Dragonfly: Bill Haney's Dragonfly nabs former Cerevel CFO; Cellectis' new CMO
May 21, 2024
Contract Pharma
Dragonfly: Dragonfly, Merck Partner to Evaluate DF9001 in Combination with Keytruda
Mar 05, 2024
Contract Pharma
Dragonfly: Dragonfly Achieves AbbVie Milestone
Feb 16, 2024
Pharamceutical Technology
Dragonfly: Dragonfly and Gilead enter partnership for cancer therapy
Feb 15, 2024
Yahoo
Dragonfly: Dragonfly Announces Clinical Collaboration Exploring Combinations of Dragonfly's DF1001 HER-2 TriNKET with Gilead's Trodelvy in two Cancer Indications
Dec 05, 2023
StreetInsider
Press Release: Dragonfly : Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in Patients with Advanced Solid Tumors
Jul 13, 2023
Benzinga
Dragonfly: Genedata Announces Partnership with Dragonfly Therapeutics to Support Novel Immune Engager R&D
Jun 05, 2023
FinanzNachrichten
Dragonfly: Dragonfly Therapeutics, Inc.: Dragonfly Therapeutics Announces the Presentation of Phase 1 DF1001 TriNKET Dose Escalation Results at ASCO 2023 Annual Meeting
Jun 02, 2023
Contract Pharma
Dragonfly: Dragonfly Therapeutics Expands Clinical Leadership Team
Dragonfly Competitors
1
2
3
4
5
6
7
8
9
10